PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,831 stories, page 624 of 748

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Takeda Pharmaceutical Co. Ltd. – TSE:4502

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab’s Epcoritamab Plus Lenalidomide Meets Phase 3 Goal in Relapsed DLBCL

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Number of shares and votes in Active Biotech

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Number of shares and votes in Active Biotech

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rats, cockroaches found in 6 Mumbai restaurants, FDA suspends licences

RediffOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mumbai food dept finds rats, cockroaches, expired food at six eateries located in Nariman Point, Borivali,

The Economic TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Class A – SZSE:300357

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A – SSE:600196

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A – SSE:600196

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0

TradingViewOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfda.govTier 1 Β· Regulatory source

Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers due to Risk for Patient Complications

BioZorb Markers are implantable and used to mark soft tissue for procedures. They are being recalled...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Doctor at OU Health leads new clinical trial for stage 1 lung cancer patients

KFOR.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong draws royalties giant as mainland China biotech licensing heats up

South China Morning PostOriginal source
πŸ‡―πŸ‡΅Industrysumitomo-pharma.comTier 1 Β· Company source

Consolidated Financial Statements for Years ended March 31, 2026 and 2025

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ: LEGN) CEO disposes shares to cover RSU tax

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does Recursion (RXRX) Russell Value Index Lift Recast Its AI Biotech Story as Deep Value?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Evaluating Oral BTK Inhibitor Remibrutinib in Phase 3 Study for Generalized Myasthenia Gravis: The RELIEVE Trial

NeurologyLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Compound pharmacies are outrunning regulations. Experts want tougher oversight.

Houston ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Contribution] From ownership to connection: What BIO USA says about the next 50 years of biotech

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System

The Malaysian ReserveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Abivax reports phase 3 ulcerative colitis trial results By Investing.com

Investing.com AustraliaOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)

In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for publi...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

World Trade Center Health Program; Petitions 024, 042, 046, 047, 051, 056, 058, and 067-Ischemic Heart Disease; Finding of Insufficient Evidence

The Administrator of the World Trade Center Health Program received eight petitions (Petitions 024,...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Office of the Director, National Institutes of Health; Notice of Meeting

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Importer of Controlled Substances Application: United States Pharmacopeial Convention

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of con...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.

Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)

Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of con...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Statement of Organization, Functions, and Delegations of Authority

This notice sets forth the Statement of Organization of the Office for Civil Rights of the U.S. Depa...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation

The Food and Drug Administration (FDA) is classifying the monitor for opioid induced impairment of o...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis

The Food and Drug Administration (FDA) is classifying the skin patch for treatment of hyperhidrosis...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Submission for Office of Management and Budget Review; Adoption and Foster Care Analysis and Reporting System (AFCARS)

The Administration for Children and Families (ACF) is requesting a revision of the Adoption and Fost...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Center for Scientific Review; Notice of Closed Meeting

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryfederalregister.govTier 1 Β· Regulatory source

Privacy Act of 1974; Matching Program

In accordance with the Privacy Act of 1974, as amended, the Department of Health and Human Services...

Federal RegisterOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Lenvima

Official structured record identifier: f4bedd21-efde-44c6-9d9c-b48b78d7ed1e.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: LEQEMBI

Official structured record identifier: 9d1ff786-e577-410a-a273-c4d7d0e4e975.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Childrens Fluticasone Propionate ALLERGY RELIEF

Official structured record identifier: 9aaa30cf-1e3b-4382-91dc-568067a4b0ac.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Loperamide Hydrochloride

Official structured record identifier: 52e6ecc5-5f3d-9989-e063-6294a90af2dc.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: NYSTATIN

Official structured record identifier: 50737729-a4a4-e747-e063-6394a90adcc5.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: LISDEXAMFETAMINE DIMESYLATE

Official structured record identifier: 281842ea-d165-4b6d-a366-791239be8c2e.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Losartan Potassium

Official structured record identifier: 25c93638-7016-47d2-a57c-e4a5245ca41b.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Ultra Strength Antacid

Official structured record identifier: 24cec2bc-cf12-b513-e063-6394a90a9447.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Naloxone Hydrochloride

Official structured record identifier: 21d20dff-6efe-481e-a5a0-9c80ded73ca9.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Ibuprofen

Official structured record identifier: 1e6f3ce7-e8a3-40e8-8437-523ef5277b2e.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Lithium Carbonate

Official structured record identifier: 1c320bff-b4d5-42f2-b2b5-238564fe9589.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: escitalopram

Official structured record identifier: 1b2ec266-be5b-9265-e063-6294a90a10e3.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: ENEMEEZ Plus

Official structured record identifier: 1670ca59-7275-4ac6-bef4-674a7b24c7b3.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: unspecified product

Official structured record identifier: 0c2d7295-c0db-448e-bccf-6f2393d8505e.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: ENEMEEZ

Official structured record identifier: 0b06445d-0839-497e-bdff-e0fe224a7738.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Acetaminophen

Official structured record identifier: 08f5742a-7bc8-5786-e063-6294a90a347d.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Degree

Official structured record identifier: 04d81361-885e-cd25-e063-6394a90aa78b.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Topcare Nicotine

Official structured record identifier: 03d9708a-923c-4fd3-ac3d-6ab4a4d8a804.

openFDA Drug LabelsOriginal source
πŸ‡ΊπŸ‡ΈRegulatoryopen.fda.govTier 1 Β· Regulatory source

Drug label update: Finasteride

Official structured record identifier: 03429cec-c6b5-47fe-bb11-6b42f977df7e.

openFDA Drug LabelsOriginal source
πŸ‡ͺπŸ‡ΊResearcheuropepmc.orgTier 2 Β· Direct publisher

Nanomaterials for Wound Healing: Mechanisms and Challenges.

Europe PMCOriginal source
πŸ‡ͺπŸ‡ΊResearcheuropepmc.orgTier 2 Β· Direct publisher

IMPACT-Introduction of Mycotic Prophylaxis At Cystectomy Trial: perioperative mycotic prophylaxis with fluconazole to reduce postoperative complications following cystectomy-study protocol for a national multi-center, double-blinded, placebo-controlled, randomized clinical trial.

Europe PMCOriginal source